|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar
|
|
2
|
LaCasse EC, Baird S, Korneluk RG and
MacKenzie AE: The inhibitors of apoptosis (IAPs) and their emerging
role in cancer. Oncogene. 17:3247–3259. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Altieri DC and Marchisio PC: Survivin
apoptosis: an interloper between cell death and cell proliferation
in cancer. Lab Invest. 79:1327–1333. 1999.PubMed/NCBI
|
|
4
|
Reed JC: The Survivin saga goes in vivo. J
Clin Invest. 108:965–969. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Geske FJ and Gerschenson LE: The biology
of apoptosis. Hum Pathol. 32:1029–1038. 2001. View Article : Google Scholar
|
|
6
|
Ambrosini G, Adida C and Altieri DC: A
novel anti-apoptosis gene, survivin, expressed in cancer and
lymphoma. Nat Med. 3:917–921. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Adida C, Crotty PL, McGrath J, Berrebi D,
Diebold J and Altieri DC: Developmentally regulated expression of
the novel cancer anti-apoptosis gene survivin in human and mouse
differentiation. Am J Pathol. 152:43–49. 1998.PubMed/NCBI
|
|
8
|
Tamm I, Wang Y, Sausville E, et al:
IAP-family protein survivin inhibits caspase activity and apoptosis
induced by Fas (CD95), Bax, caspases, and anticancer drugs. Cancer
Res. 58:5315–5320. 1998.PubMed/NCBI
|
|
9
|
Sun PL, Jin Y, Kim H, et al: Survivin
expression is an independent poor prognostic marker in lung
adenocarcinoma but not in squamous cell carcinoma. Virchows Arch.
463:427–436. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kawasaki H, Altieri DC, Lu CD, Toyoda M,
Tenjo T and Tanigawa N: Inhibition of apoptosis by survivin
predicts shorter survival rates in colorectal cancer. Cancer Res.
58:5071–5074. 1998.PubMed/NCBI
|
|
11
|
Krieg A, Werner TA, Verde PE, Stoecklein
NH and Knoefel WT: Prognostic and clinicopathological significance
of survivin in colorectal cancer: a meta-analysis. PLoS One.
8:e653382013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ito T, Shiraki K, Sugimoto K, et al:
Survivin promotes cell proliferation in human hepatocellular
carcinoma. Hepatology. 31:1080–1085. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Pizem J, Marolt VF, Luzar B and Cör A:
Proliferative and apoptotic activity in hepatocellular carcinoma
and surrounding non-neoplastic liver tissue. Pflugers Arch. 442(6
Suppl 1): R174–R176. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ikeguchi M, Hirooka Y and Kaibara N:
Quantitative analysis of apoptosis-related gene expression in
hepatocellular carcinoma. Cancer. 95:1938–1945. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ikeguchi M, Ueta T, Yamane Y, Hirooka Y
and Kaibara N: Inducible nitric oxide synthase and survivin
messenger RNA expression in hepatocellular carcinoma. Clin Cancer
Res. 8:3131–3136. 2002.PubMed/NCBI
|
|
16
|
Monzó M, Rosell R, Felip E, et al: A novel
anti-apoptosis gene: Re-expression of survivin messenger RNA as a
prognosis marker in non-small-cell lung cancers. J Clin Oncol.
17:2100–2104. 1999.PubMed/NCBI
|
|
17
|
Nakagawara A: Molecular basis of
spontaneous regression of neuroblastoma: role of neurotrophic
signals and genetic abnormalities. Hum Cell. 11:115–124.
1998.PubMed/NCBI
|
|
18
|
Fields AC, Cotsonis G, Sexton D,
Santoianni R and Cohen C: Survivin expression in hepatocellular
carcinoma: correlation with proliferation, prognostic parameters,
and outcome. Mod Pathol. 17:1378–1385. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ambrosini G, Adida C, Sirugo G and Altieri
DC: Induction of apoptosis and inhibition of cell proliferation by
survivin gene targeting. J Biol Chem. 273:11177–11182. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Olie RA, Simões-Wüst AP, Baumann B, et al:
A novel antisense oligonucleotide targeting survivin expression
induces apoptosis and sensitizes lung cancer cells to chemotherapy.
Cancer Res. 60:2805–2809. 2000.PubMed/NCBI
|
|
21
|
Pagano M, Pepperkok R, Verde F, Ansorge W
and Draetta G: Cyclin A is required at two points in the human cell
cycle. EMBO J. 11:961–971. 1992.PubMed/NCBI
|
|
22
|
Stacey DW: Cyclin D1 serves as a cell
cycle regulatory switch in actively proliferating cells. Curr Opin
Cell Biol. 15:158–163. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Suzuki A, Hayashida M, Ito T, et al:
Survivin initiates cell cycle entry by the competitive interaction
with Cdk4/p16(INK4a) and Cdk2/cyclin E complex activation.
Oncogene. 19:3225–3234. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Vong QP, Cao K, Li HY, Iglesias PA and
Zheng Y: Chromosome alignment and segregation regulated by
ubiquitination of survivin. Science. 310:1499–1504. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Vader G, Kauw JJ, Medema RH and Lens SM:
Survivin mediates targeting of the chromosomal passenger complex to
the centromere and midbody. EMBO Rep. 7:85–92. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Nakamura M, Tsuji N, Asanuma K, et al:
Survivin as a predictor of cis-diamminedichloroplatinum sensitivity
in gastric cancer patients. Cancer Sci. 95:44–51. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang X, Wong SC, Pan J, et al: Evidence of
cisplatin-induced senescent-like growth arrest in nasopharyngeal
carcinoma cells. Cancer Res. 58:5019–5022. 1998.PubMed/NCBI
|
|
28
|
Joe AK, Liu H, Suzui M, Vural ME, Xiao D
and Weinstein IB: Resveratrol induces growth inhibition, S-phase
arrest, apoptosis, and changes in biomarker expression in several
human cancer cell lines. Clin Cancer Res. 8:893–903.
2002.PubMed/NCBI
|
|
29
|
Lee BJ, Chon KM, Kim YS, et al: Effects of
cisplatin, 5-fluorouracil, and radiation on cell cycle regulation
and apoptosis in the hypopharyngeal carcinoma cell line.
Chemotherapy. 51:103–110. 2005. View Article : Google Scholar : PubMed/NCBI
|
